BAD/BCL-xL heterodimerization leads to bypass of G0/G1 arrest
- 27 July 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (33) , 4507-4518
- https://doi.org/10.1038/sj.onc.1204584
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 39 references indexed in Scilit:
- Growth Factors Inactivate the Cell Death Promoter BAD by Phosphorylation of Its BH3 Domain on Ser155Journal of Biological Chemistry, 2000
- 14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain PhosphorylationMolecular Cell, 2000
- Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse modelOncogene, 1999
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.The Journal of Experimental Medicine, 1996
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992
- Effects of an Rb mutation in the mouseNature, 1992
- Requirement for a functional Rb-1 gene in murine developmentNature, 1992
- Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.The Journal of cell biology, 1975